Netbasequid

FEBRUARY 22, 2021

In their paper on Deep Tech: The Great Wave of Innovation , BCG and Hello Tomorrow explain “what deep tech is, how it works, how different stakeholders can contribute to it, and how it can be harnessed for competitive advantage.” Investment intelligence to inform deep tech understanding. Patents Reveal Emerging Innovations.

Biotech 98

Biotech Innovation Intellectual Property Market Research 98

Alpha Sense BI

FEBRUARY 8, 2023

Specifically, within the pharma and biotech sectors, there have been 22 deals announced so far in 2023 — again, a low number compared to the 70 made over the same period last year. Additionally, unprofitable biopharma, aka most biotech companies, is expected to invest $1.1 In 2021, Spinraza sales reached $1.9

Biotech 96

Biotech Research Innovation Capital 96

Alpha Sense BI

AUGUST 30, 2023

Research shows that the AI in asset management market will grow at a staggering 34% CAGR through 2027. The time is now to invest in a market intelligence platform with AI search capabilities, so you can speed up your research and outperform the market. Artificial intelligence is the only way to do it.

Management 98

Management Due Diligence Biotech Algorithm 98

Alpha Sense BI

MAY 28, 2024

Below, we explore the factors constraining venture capital funding into the first half of the year, and the ways investors can leverage crucial market intelligence to gain a competitive advantage in the shifting landscape. The VC Funding Dryspell Venture capital investment fell to the lowest activity in nearly five years for Q1 2024.

Capital 69

Capital Startups Due Diligence Biotech 69

BIS Research

MARCH 19, 2019

Precision medicine is an innovative approach to prevent and treat diseases by taking into account the individual distinction between genetic make-up, lifestyle, and environment of an individual. It is sometimes also known as personalized medicine. billion in 2018 and is expected to reach $216.75 billion by 2028.

Globalization 64

Globalization Biotech Marketing Marketing 64

Sedulo

MARCH 15, 2023

Key Takeaways from the Assessment: While several insights were uncovered by analyzing trial clusters and the different IO drug modalities and sponsors, a few key takeaways from the data included: China emerging as innovation hub for IO therapies Smaller pharma/biotech conducting trials for emerging IO technologies Chinese and US small pharma/biotech (..)

Biotech 52

Biotech Competitive Landscape Pharmaceutical Benchmarking 52

Alpha Sense BI

APRIL 29, 2024

Market Intelligence at Scale : GenAI has the potential to securely pair a company’s internal content with leading premium market content sources using proprietary large language models (LLMs) and genAI trained on both business and financial content. The renewable energy sub-sector is also seeing promising activity.

Capital 52

Capital Due Diligence Biotech Startups 52